Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
This Growth Stock Has Market-Beating Potential
10:30am, Sunday, 10'th Apr 2022 The Motley Fool
The stock surged 3,400% over the past two years.
This Growth Stock Has Market-Beating Potential
06:30am, Sunday, 10'th Apr 2022
The stock surged 3,400% over the past two years.
These COVID Stocks Will Be Incredibly Profitable
11:30am, Saturday, 09'th Apr 2022 The Motley Fool
As COVID-19 becomes endemic, what will the market look like for therapies and vaccines?
3 Pharmaceutical Stocks With Awesome Futures
11:15am, Saturday, 09'th Apr 2022 The Motley Fool
The market is so pessimistic about anything COVID-related that everything has gotten super cheap.
This Cheap Stock Is Making Billions in Biotech
10:45am, Saturday, 09'th Apr 2022 The Motley Fool
With FDA authorization likely on the horizon, Novavax is positioned for even greater success.
These COVID Stocks Will Be Incredibly Profitable
07:30am, Saturday, 09'th Apr 2022
As COVID-19 becomes endemic, what will the market look like for therapies and vaccines?
3 Pharmaceutical Stocks With Awesome Futures
07:15am, Saturday, 09'th Apr 2022
The market is so pessimistic about anything COVID-related that everything has gotten super cheap.
This Cheap Stock Is Making Billions in Biotech
06:45am, Saturday, 09'th Apr 2022
With FDA authorization likely on the horizon, Novavax is positioned for even greater success.
Why Novavax Stock Topped the Market on Friday
10:02pm, Friday, 08'th Apr 2022 The Motley Fool
The company's coronavirus vaccine is authorized for use in another Asian country.
Novavax (NVAX) Gains As Market Dips: What You Should Know
09:45pm, Friday, 08'th Apr 2022 Zacks Investment Research
Novavax (NVAX) closed the most recent trading day at $60.63, moving +1.9% from the previous trading session.
Why Novavax Stock Topped the Market on Friday
06:02pm, Friday, 08'th Apr 2022
The company's coronavirus vaccine is authorized for use in another Asian country.
Why Novavax Stock Dropped 23.6% This Week
04:20pm, Friday, 08'th Apr 2022 The Motley Fool
The company is still waiting for the FDA to give Emergency Use Authorization for its COVID-19 vaccine.
Why Novavax Stock Dropped 23.6% This Week
12:20pm, Friday, 08'th Apr 2022
The company is still waiting for the FDA to give Emergency Use Authorization for its COVID-19 vaccine.
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
02:27pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Vaccine Makers Down on FDA Meeting, Novavax Most at Risk
12:21pm, Thursday, 07'th Apr 2022
The major covid-19 vaccine makers are all down, anticipating bad-for-business news from the FDA. However, NVAX stock has the most to lose.
